However, thus far, the only documented substrates for ADAMTS-15 are VCAN [57] and aggrecan [46], while in breast cancer, where the effects of ADAMTS-15 on cell migration were shown to involve syndecan-4, this was independent of its metalloproteinase activity [46]. Here, ADAMTS15 is linked to breast carcinoma.